These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 2893264

  • 1. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
    Gulya K, Lui GK, Pelton JT, Kazmierski W, Hruby VJ, Yamamura HI.
    NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264
    [Abstract] [Full Text] [Related]

  • 2. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
    Hawkins KN, Knapp RJ, Lui GK, Gulya K, Kazmierski W, Wan YP, Pelton JT, Hruby VJ, Yamamura HI.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
    [Abstract] [Full Text] [Related]

  • 3. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 Jan; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 4. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
    Kramer TH, Shook JE, Kazmierski W, Ayres EA, Wire WS, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
    [Abstract] [Full Text] [Related]

  • 5. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B, Connor M, Christie MJ.
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [Abstract] [Full Text] [Related]

  • 6. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
    Pelton JT, Kazmierski W, Gulya K, Yamamura HI, Hruby VJ.
    J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
    [Abstract] [Full Text] [Related]

  • 7. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE, Pelton JT, Lemcke PK, Porreca F, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
    [Abstract] [Full Text] [Related]

  • 8. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY, Yang HH, Li S, Adams JU.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE, Kazmierski W, Wire WS, Lemcke PK, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [Abstract] [Full Text] [Related]

  • 11. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
    Schoffelmeer AN, Warden G, Hogenboom F, Mulder AH.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):237-42. PubMed ID: 1677039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE, Harrison LM, Ge LJ, Kastin AJ, Chang SL.
    J Pharmacol Exp Ther; 1994 Sep 01; 270(3):1086-96. PubMed ID: 7932156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G, Haskell-Luevano C, Kendall L, Bonner G, Hadley ME, Cone RD, Hruby VJ.
    J Med Chem; 2004 Mar 11; 47(6):1514-26. PubMed ID: 14998337
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I, Napier TC.
    J Pharmacol Exp Ther; 1995 Mar 11; 272(3):1260-70. PubMed ID: 7891342
    [Abstract] [Full Text] [Related]

  • 19. Quantitative autoradiography of [3H]CTOP binding to mu opioid receptors in rat brain.
    Hawkins KN, Knapp RJ, Gehlert DR, Lui GK, Yamamura MS, Roeske LC, Hruby VJ, Yamamura HI.
    Life Sci; 1988 Mar 11; 42(25):2541-51. PubMed ID: 2898716
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.